{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:36:58Z","timestamp":1792795018414,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,5]]},"DOI":"10.4103\/0366-6999.198932","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T09:36:34Z","timestamp":1485250594000},"page":"280-287","source":"Crossref","is-referenced-by-count":3,"title":["Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma"],"prefix":"10.1097","volume":"130","author":[{"given":"Jun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Mei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210129","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: Pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems","volume":"16","author":"Vang","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1101\/gad.973602","article-title":"P53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas","volume":"16","author":"Singh","year":"2002","journal-title":"Genes Dev"},{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molcel.2007.02.017","article-title":"PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms","volume":"25","author":"Brognard","year":"2007","journal-title":"Mol Cell"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: Navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"R5-6-20210129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/j.gastro.2011.10.026","article-title":"The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation","volume":"142","author":"Nitsche","year":"2012","journal-title":"Gastroenterology"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2004.08.009","article-title":"RAD51, genomic stability, and tumorigenesis","volume":"218","author":"Richardson","year":"2005","journal-title":"Cancer Lett"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1186\/s12885-015-1711-1","article-title":"High PHLPP expression is associated with better prognosis in patients with resected lung adenocarcinoma","volume":"15","author":"Lv","year":"2015","journal-title":"BMC Cancer"},{"key":"R8-6-20210129","first-page":"2963","article-title":"Activation of FOXO3a suggests good prognosis of patients with radically resected gastric cancer","volume":"8","author":"Yu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R9-6-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bjc.6602665","article-title":"High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients","volume":"93","author":"Qiao","year":"2005","journal-title":"Br J Cancer"},{"key":"R10-6-20210129","first-page":"2151","article-title":"Overexpression of catalytic subunit M2 in patients with ovarian cancer","volume":"125","author":"Wang","year":"2012","journal-title":"Chin Med J"},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/onc.2008.450","article-title":"Loss of PHLPP expression in colon cancer: Role in proliferation and tumorigenesis","volume":"28","author":"Liu","year":"2009","journal-title":"Oncogene"},{"key":"R12-6-20210129","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCRESAHA.109.215020","article-title":"PHLPP-1 negatively regulates Akt activity and survival in the heart","volume":"107","author":"Miyamoto","year":"2010","journal-title":"Circ Res"},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1475-4924-2-20","article-title":"The Drosophilaforkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling","volume":"2","author":"J\u00fcnger","year":"2003","journal-title":"J Biol"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4331\/wjbc.v5.i3.346","article-title":"FoxO3a and disease progression","volume":"5","author":"Nho","year":"2014","journal-title":"World J Biol Chem"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1158\/0008-5472.CAN-09-4524","article-title":"Activation of FOXO3a is sufficient to reverse mitogen-activated protein\/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res"},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1158\/0008-5472.CAN-06-4327","article-title":"Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells","volume":"67","author":"Belguise","year":"2007","journal-title":"Cancer Res"},{"key":"R17-6-20210129","doi-asserted-by":"crossref","first-page":"10760","DOI":"10.1158\/0008-5472.CAN-06-1111","article-title":"Chronic protein kinase B (PKB\/c-Akt) activation leads to apoptosis induced by oxidative stress-mediated Foxo3a transcriptional up-regulation","volume":"66","author":"van Gorp","year":"2006","journal-title":"Cancer Res"},{"key":"R18-6-20210129","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.1158\/0008-5472.CAN-11-0295","article-title":"FOXO3a-Dependent mechanism of E1A-induced chemosensitization","volume":"71","author":"Su","year":"2011","journal-title":"Cancer Res"},{"key":"R19-6-20210129","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/carcin\/bgn130","article-title":"Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells","volume":"29","author":"Ko","year":"2008","journal-title":"Carcinogenesis"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.198932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:42:08Z","timestamp":1623958928000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201702050-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.198932","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2,5]]}}}